RARE position history
The shares of Ultragenyx Pharmaceutical In (RARE) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 16,000 shares, $368K, 0.09% of portfolio, New
- 2026 Q1: 61,100 shares, $1.3M, 0.29% of portfolio, Add +281.9%
- 2026 Q2: 47,100 shares, $1.6M, 0.30% of portfolio, Reduce −22.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|